icometrix offers imaging biomarkers for anatomical MRI or CT images as well as for functional, diffusion and perfusion MR images. Medical imaging serves as an endpoint in an increasing number of clinical trials for neurological disorders to evaluate the effectiveness of novel therapeutic options and to better understand the pathophysiology. It is critical to obtain objective imaging measurements.Therefore, the use of high-quality MRI data and quantitative MRI biomarkers is also recommended in the latest guidelines of the European Medicine Agency on clinical investigation of medicinal products for treatment of dementia, multiple sclerosis and other neurological disorders.